The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly and Co. (LLY) emerged as a beacon of optimism last week in a market filled with uncertainty and volatility. Shares soared over 14% ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly stock shot higher as its pill-form weight loss drug candidate cleared one of several Phase III hurdles. VKTX and NVO traded lower.

Eli Lilly's current streak only goes back to 2015. But while Altria has a more impressive track record, that doesn't necessarily make it a better dividend growth stock. Prior to the Great ...

Unlock comprehensive insights into our analysis of Eli Lilly stock in this financial health report.